Janssen Pharmaceutica N.v., Belgium

This study aims to observe and document how standard treatments for relapsed multiple myeloma perform in real-world clinical practice, not in a controlled trial. It will follow 300 patients who have already tried several other treatments, tracking how well the treatments work, th…